HPTLC Method Development and Validation of Genistein and Daidzein Estimation in Mucuna cochinchinensis Seed Extracts
DOI:
https://doi.org/10.37591/rrjodfdp.v7i1.722Abstract
Aim: The current study was designed with the objective to estimate the concentration of Genistein and Daidzein in ethyl acetate extract of Mucuna cochinchinensis by high-performance thin-layer chromatography (HPTLC).Methods: The separation of bioactive compounds was performed using mobile phase, Toluene: n-Butanol: Glacial Acetic Acid: Water (1:4:2:2) and detected at wavelength 254 nm. The method was validated for linearity, accuracy, precision, limit of detection (LOD) and limit of quantification (LOQ) by the International Conference on Harmonization guidelines (ICH). Results: The calibration range was found to be 10–50 and 20–100 ng/band for Genistein and Daidzein, respectively. Daidzein was separated with a Rf value of 0.34 and Genistein with a Rf value of 0.47. Average recovery was 99.96% and 99.90% for Genistein and Daidzein, respectively. The LOD and LOQ were 0.89 ng and 2.98 ng for Genistein, and 5.1 ng and 17.29 ng for Daidzein, respectively. Conclusion: The developed HPTLC method was simple, precise, robust, specific, rapid and cost effective and could be used for quality control analysis and quantification of Genistein and Daidzein in different herbal formulations containing the plant species.
Keywords: Daidzein, Genistein, high-performance thin-layer chromatography (HPTLC), Isoflavones, M. cochinchinensis, method validation
Cite this Article
K. Natarajan, S. Sangeetha, Vineeth Chandy. HPTLC Method Development and Validation of Genistein and Daidzein Estimation in Mucuna cochinchinensis Seed Extracts. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2020; 7(1): 16–25p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |